B

Breast Cancer Research Centre - WA | Nedlands, Australia

Research site
(Unclaimed)
Location
91, Monash Avenuenue, Suite 407, Level 4, Nedlands, Western Australia, Australia
Site insights

Top conditions

Breast Cancer (4 trials)

Triple Negative Breast Cancer (1 trial)

Colorectal Cancer (1 trial)

Cancer (1 trial)

Neoplasm Metastasis (1 trial)

Top treatments

Palbociclib
Nivolumab
Anastrozole
Trastuzumab
SBT6050

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors

A first-in-human (FIH) study using SBT6050 and SBT6050 in combination with PD-1 inhibitors in HER2 expressing or amplified advanced malignancies

Active, not recruiting
HER2 Positive Solid Tumors
Drug: SBT6050
Drug: Cemiplimab

Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy are at higher risk...

Active, not recruiting
HER2-Positive Primary Breast Cancer
Residual Invasive Breast Cancer
Drug: DS-8201a
Drug: T-DM1

This is a prospective, two arm, international, multicenter, randomized, open-label Phase III study evaluating the addition of 2 years of palbociclib...

Active, not recruiting
Breast Cancer
Drug: Standard Adjuvant Endocrine Therapy
Drug: Palbociclib

Trial sponsors

A

Alliance Foundation Trials (AFT) (1 trial)

Amgen logo

Amgen (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems